Newly Identified Molecule May Clarify Muscle Loss in Type 2 Diabetes
Scientists have discovered a new molecule, TMEM9B-AS1, that may explain muscle loss in people with type 2 diabetes, offering potential for targeted treatments.
Researchers at Karolinska Institutet have uncovered a novel molecule that could explain the common occurrence of muscle weakness and atrophy in individuals with type 2 diabetes. This discovery, published in Science Advances, focuses on a previously unknown long non-coding RNA known as TMEM9B-AS1. This molecule plays a crucial role in regulating muscle cell functions and its levels are significantly decreased in the skeletal muscles of people with type 2 diabetes. The deficiency of TMEM9B-AS1 impairs the cellular processes involved in muscle protein synthesis, contributing to muscle degradation.
The study reveals that TMEM9B-AS1 supports the stability of the MYC gene, a vital driver of ribosome production—the cellular machinery responsible for protein synthesis. When TMEM9B-AS1 levels drop, MYC becomes unstable, leading to disrupted protein production in muscle cells. This mechanism helps explain the muscle deterioration frequently observed in patients with metabolic diseases like type 2 diabetes.
According to first author Ilke Sen from the Department of Physiology and Pharmacology, the absence of TMEM9B-AS1 hampers the ribosomal biogenesis process, resulting in weakened muscle tissue. This groundbreaking insight not only enhances understanding of muscle pathology in diabetes but also opens potential avenues for targeted therapies aimed at restoring muscle mass and strength in affected individuals.
This discovery underscores the importance of molecular research in uncovering the intricacies of metabolic diseases and highlights new possibilities for improving muscle health in people living with type 2 diabetes.
Source: https://medicalxpress.com/news/2025-07-newly-molecule-muscle-mass-diabetes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How CAR-T Cell Therapy Is Transforming Cancer Treatment
Discover how CAR-T cell therapy is transforming cancer treatment by harnessing genetically engineered immune cells to target and destroy tumors with unprecedented precision and strength.
How APOL1 Mutations Impact Mitochondrial Function in Kidney Disease Revealed by Organoid Models
New research using kidney organoids uncovers how APOL1 gene mutations impair mitochondrial function, shedding light on mechanisms behind genetic kidney disease and opening doors for targeted therapies.
Research Indicates Sexual Satisfaction Remains Significant for Women Throughout Menopause Transition
A recent study shows that sexual pleasure remains vital for women across menopause, with many maintaining orgasm satisfaction and embracing self-pleasure despite age-related changes.
High Risk of Sudden Cardiac Death in Male Bodybuilders, Especially Competitors
A significant number of sudden cardiac deaths have been reported among male bodybuilders, especially professionals, highlighting the health risks associated with extreme training and substance use. This research urges safer practices and medical supervision to protect athletes' heart health.